Amedeo Smart

Free Medical Literature Service

 

Amedeo

Breast Cancer
  Free Subscription

Articles published in
J Surg Oncol
    February 2026
  1. CRISTOFALO MM, Maesaka JY, Pereira DA, Nobrega GB, et al
    Neoadjuvant Chemotherapy in Triple Negative Breast Cancer: A Systematic Review of Breast and Node Pathologic Response.
    J Surg Oncol. 2026 Feb 15. doi: 10.1002/jso.70213.
    >> Share

    January 2026
  2. NGUYEN AT, Duckworth ED, Li RA, Galiano RD, et al
    Disparities in Breast Cancer Screening, Diagnosis, and Outcomes Among Vietnamese American Women: A Systematic Review.
    J Surg Oncol. 2026 Jan 14. doi: 10.1002/jso.70164.
    >> Share

  3. HICKEY A, De la Cruz Ku G, King C, Franco C, et al
    Do Racial and Income Disparities Exist in the Application of 21-Gene Recurrence Score?
    J Surg Oncol. 2026;133:16-30.
    >> Share

    December 2025
  4. ESGUEVA AJ, Tomatis M, Ponti A, Marotti L, et al
    Changing Practices in Axillary Surgery After Neoadjuvant Breast Cancer Therapy: Insights From the EUSOMA European Database.
    J Surg Oncol. 2025 Dec 18. doi: 10.1002/jso.70158.
    >> Share

  5. DE LA CRUZ KU G, Desai A, Ho I, King C, et al
    Post-Operative Outcomes Across the Levels of Oncoplastic Breast Surgery According to the American Society of Breast Surgeons Oncoplastic Surgery Definition and Classification System.
    J Surg Oncol. 2025;132:1307-1316.
    >> Share

    November 2025
  6. ALBUAINAIN RY, Althawadi R, Eid R, Abdulla HA, et al
    Oncological Outcomes of Omitting Axillary Surgery in Early Breast Cancer: A Systematic Review and Meta-Analysis.
    J Surg Oncol. 2025 Nov 26. doi: 10.1002/jso.70145.
    >> Share

  7. AUBREY JM, Liefeld HR, Armstrong C, Levine A, et al
    Prospective Review of Practice Patterns in Breast Cancer Surgery Facilitates Rapid Practice Change, Reduced Clinical Variation, and Cost Savings.
    J Surg Oncol. 2025 Nov 16. doi: 10.1002/jso.70130.
    >> Share

  8. DA SILVA LFCM, Carneiro FP, Motoyama AB
    MicroRNA Expression in Breast Cancer Patients, an Integrative Review.
    J Surg Oncol. 2025 Nov 16. doi: 10.1002/jso.70132.
    >> Share

  9. WANG L, Zhou J, Zhao H
    Letter to the Editor: Comment on: "Factors Associated With Residual Positive Lymph Nodes With Targeted Axillary Lymph Node Dissection for Breast Cancer and Accuracy of Clipped Node Retrieval in Non-Mapping Patients".
    J Surg Oncol. 2025 Nov 6. doi: 10.1002/jso.70126.
    >> Share

  10. GOLDHABER NH, O'Keefe TJ, Longo L, Blair SL, et al
    Effect of Neoadjuvant Hormonal Therapy on Breast Conservation in Invasive Ductal Versus Lobular Carcinoma of the Breast: A Comparative Analysis.
    J Surg Oncol. 2025;132:1011-1018.
    >> Share

  11. GHOSH K, Kuchta K, Alva D, Seth AK, et al
    Is Prepectoral Implant Reconstruction Associated With Better Physical Well-Being?
    J Surg Oncol. 2025;132:1071-1075.
    >> Share

    October 2025
  12. ALTUNDAG K
    Liquid Biopsy in Metastatic Breast Cancer: Adoption Lags Despite Growing Evidence.
    J Surg Oncol. 2025 Oct 10. doi: 10.1002/jso.70107.
    >> Share

  13. KIM M, Gilliland JL, Jiang CZ, Parnes MF, et al
    Sexual Health in Postmastectomy Breast Reconstruction Patients and Value of an Intervention: A Qualitative Study.
    J Surg Oncol. 2025;132:825-835.
    >> Share

  14. WANG X, Shao Z, Zhu H, Zhang Q, et al
    Evolving Trends in Postmastectomy Breast Reconstruction With Autologous Tissues: A Large-Scale, 24-Year Retrospective Study in China.
    J Surg Oncol. 2025;132:845-852.
    >> Share

    September 2025
  15. REDAELLI M, Steadman JA, Hoskin TL, Hieken TJ, et al
    Does RECIST 1.1 Predict Nodal Response to Neoadjuvant Chemo-Immunotherapy in Breast Cancer?
    J Surg Oncol. 2025 Sep 24. doi: 10.1002/jso.70096.
    >> Share

  16. ZHANG X, Chen Y, Wu Q, Yu Y, et al
    Safety Analysis of Omitting Radiotherapy After Breast-Conserving Surgery in Patients With Early-Stage Breast Cancer: A Meta-Analysis Based on Randomized Controlled Trials.
    J Surg Oncol. 2025 Sep 20. doi: 10.1002/jso.70091.
    >> Share

  17. NGUYEN AT, Li RA, Ontiveros NC, Adam TH, et al
    Utility of the Social Vulnerability Index in Addressing Breast Cancer Disparities: A Meta-Analysis.
    J Surg Oncol. 2025 Sep 20. doi: 10.1002/jso.70080.
    >> Share

  18. EPHRAIM R, Kar M, Sultania M, Naik S, et al
    Factors Influencing the Choice of Mastectomy Over Breast Conservation Surgery in Early Breast Cancer: A Prospective Qualitative Exploration of Patient Perspectives From India.
    J Surg Oncol. 2025 Sep 14. doi: 10.1002/jso.70088.
    >> Share

    August 2025
  19. BRABENDER DE, Griffiths A, Lu KA, Armstrong K, et al
    Factors Associated With Residual Positive Lymph Nodes With Targeted Axillary Lymph Node Dissection for Breast Cancer and Accuracy of Clipped Node Retrieval in Non-Mapping Patients.
    J Surg Oncol. 2025 Aug 21. doi: 10.1002/jso.70070.
    >> Share

  20. LIU P, Liu Y, Xie Y, Hu S, et al
    Potential of Combination of CE-MRI and Serum Her-2neu Extracellular Domain in Evaluating Effectiveness of Neoadjuvant Chemotherapy in Breast Cancer.
    J Surg Oncol. 2025 Aug 11. doi: 10.1002/jso.70058.
    >> Share

  21. KIM M, Bubberman J, Amakiri U, Kim YS, et al
    Culture Impacts Sexual Well-Being in Autologous Breast Reconstruction: A Multi-Continental Examination.
    J Surg Oncol. 2025;132:375-383.
    >> Share

  22. GABAY AJ, Chen J, Stern CS, Gibbons C, et al
    Predicting Breast Reconstruction Readmission, Reoperation, and Prolonged Length of Stay: A Machine Learning Approach.
    J Surg Oncol. 2025;132:345-353.
    >> Share

  23. LEVY J, Amakiri U, Shammas RL, Graziano FD, et al
    Longitudinal Modeling in Surgical Oncology Research: A Primer Examining Patient-Reported Outcomes.
    J Surg Oncol. 2025;132:294-307.
    >> Share

    July 2025
  24. SUPPAN I, Lundon D, Garg PK, Caballero C, et al
    Clinical Use of Liquid Biopsy in Metastatic Breast Cancer-An ESSO-EYSAC International Survey.
    J Surg Oncol. 2025 Jul 14. doi: 10.1002/jso.70045.
    >> Share

  25. WILLERT CB, Bidstrup P, Mellemkjaer L, Kalstrup J, et al
    Bilateral Risk-Reducing Mastectomy With Immediate Breast Reconstruction Lowers Concerns of Breast Cancer in Women With a High-Risk Genetic Predisposition for Breast Cancer Compared With a Radiological Imaging Surveillance Group.
    J Surg Oncol. 2025 Jul 9. doi: 10.1002/jso.70029.
    >> Share

  26. WAREHAM C, Bertaux B, Chahine E, Homsy C, et al
    Geographical Presence of Plastic Surgeons in Relation to Breast Surgeons in the United States for Breast Reconstruction.
    J Surg Oncol. 2025;132:22-27.
    >> Share

    June 2025
  27. FANNING JE, Chen A, Thomson S, Tillotson E, et al
    Epitrochlear and Humeral Lymph Nodes: A Biomarker for Deep Lymphatic Function and Implications for Breast Cancer-Related Lymphedema Risk.
    J Surg Oncol. 2025 Jun 24. doi: 10.1002/jso.70002.
    >> Share

  28. VARAGUR K, Ribaudo JG, Keller M, Fadell NR, et al
    Understanding Trends in Incidence and Management of Pregnancy-Associated Breast Cancer in a National Sample Using Claims Data.
    J Surg Oncol. 2025 Jun 19. doi: 10.1002/jso.70010.
    >> Share

  29. VASCONCELOS CS, Salgado MRT, Martins MR, Anunciacao CEC, et al
    Soluble sFas, sFasL, sPD1, and sPDL1 Analyses in the Peripheral Blood of Locally Advanced Breast Cancer Patients Before and After Neoadjuvant Chemotherapy.
    J Surg Oncol. 2025 Jun 2. doi: 10.1002/jso.27723.
    >> Share

  30. COLEMAN-BELIN JC, Kim M, Graziano FD, Boe LA, et al
    Combined Autologous Breast Reconstruction and Gynecologic Procedures: Does Timing Affect Clinical and Patient-Reported Outcomes?
    J Surg Oncol. 2025;131:1400-1406.
    >> Share

  31. STERN CS, Shammas RL, Montes ES, Boe LA, et al
    Improving the Evaluation of Aesthetic Outcomes in DIEP Flap Breast Reconstruction: Validation of the Aesthetic Grading Tool.
    J Surg Oncol. 2025;131:1407-1412.
    >> Share

  32. HUANG A, Koesters E, Garza RM, Hanson SE, et al
    A Single Institution Experience With Immediate Lymphatic Reconstruction: Impact of Insurance Coverage on Risk Reduction.
    J Surg Oncol. 2025;131:1393-1399.
    >> Share

  33. NGUYEN A, Chon J, Coles B, Galiano R, et al
    Disparities in Breast Reconstruction After Mastectomy in Southeast Asia: A Systematic Review.
    J Surg Oncol. 2025;131:1601-1619.
    >> Share

    May 2025
  34. VAN DECAR SG, Barbera EL, Adams AM, Shore JM, et al
    A Validated Ultrasound-Based Scoring System to Stratify Risk of Axillary Metastasis in Breast Cancer: AX-RADS (Axillary Imaging Reporting and Data System).
    J Surg Oncol. 2025 May 20. doi: 10.1002/jso.28159.
    >> Share

  35. DALY GE, Collins KL, Malone SE, Garreau J, et al
    Incidence of Deleterious Genetic Mutations in Newly Diagnosed Breast Cancer Patients Over the Age of 65: Is It Time to Expand Testing Parameters?
    J Surg Oncol. 2025 May 13. doi: 10.1002/jso.28151.
    >> Share

  36. CANO-LALLAVE E, Frutos-Bernal E, Anciones-Polo M, Serrano-Sanchez E, et al
    Optimizing Lymphedema Management After Breast Cancer: Predictive Risk Models in Clinical Practice.
    J Surg Oncol. 2025 May 13. doi: 10.1002/jso.28146.
    >> Share

  37. GRAZIANO FD, White DR, Plotsker EL, Shammas RL, et al
    Enhancing Patient Decision-Making in Breast Reconstruction: A Systematic Review of Decision Aid Efficacy.
    J Surg Oncol. 2025;131:1222-1235.
    >> Share

  38. ZINDANI S, Khalil M, Rashid Z, Altaf A, et al
    Association of Socio-Environmental Burden and Inequality With Cancer Screening and Mortality.
    J Surg Oncol. 2025;131:1110-1117.
    >> Share

  39. KIEFER J, Paidisetty P, Elmorsi RAI, Nguyen CHM, et al
    Contemporary Trends in Reconstruction for Patients With Sarcoma of the Breast.
    J Surg Oncol. 2025;131:1013-1023.
    >> Share

  40. GRAZIANO FD, Amakiri UO, Levy J, Shammas RL, et al
    Perioperative Venous Thromboembolism Chemoprophylaxis Does Not Increase Risk of Complications in Free Flap Breast Reconstruction.
    J Surg Oncol. 2025;131:1211-1221.
    >> Share

    April 2025
  41. DAVE N, Hajj JP, Ahmed S, Hulsman L, et al
    Immediate Breast Reconstruction for Inflammatory Breast Carcinoma: A Scoping Review.
    J Surg Oncol. 2025;131:775-781.
    >> Share

    March 2025
  42. CHIU CW, Su CM, Liao LM, Su CS, et al
    Upstaging Prediction Model to Guide the Application of Sentinel Lymph Node Biopsy in Patients With Ductal Carcinoma In Situ: A Retrospective Comparative Study.
    J Surg Oncol. 2025;131:571-579.
    >> Share

    February 2025
  43. CLARK P, DiPasquale A, Cocco D, Brown A, et al
    Oncoplastic Surgery: Where Are We Now?
    J Surg Oncol. 2025;131:124-132.
    >> Share

  44. MCADAMS CD, Clevenger N, Nicholson K, Pesce C, et al
    Proportion of Patients With Ductal Carcinoma In Situ That Qualify for Observation Criteria Set Forth by Clinical Trials.
    J Surg Oncol. 2025;131:115-123.
    >> Share

  45. LEFF DR
    Technologies and techniques to improve precision in breast conserving surgery.
    J Surg Oncol. 2025;131:108-114.
    >> Share

    January 2025
  46. DE LA CRUZ KU G, Desai A, Hickey A, Valcarcel B, et al
    Disparities in Triple Negative Breast Cancer Among Hispanic Population Living in Latin America Versus the United States.
    J Surg Oncol. 2025 Jan 13. doi: 10.1002/jso.28088.
    >> Share

    December 2024
  47. ARREY EN, GoPaul D, Anderson D, Okoli J, et al
    Addressing Breast Cancer Disparities: A Comprehensive Approach to Health Equity.
    J Surg Oncol. 2024 Dec 19. doi: 10.1002/jso.28011.
    >> Share

  48. WANG X, Jin J, Zhu Y, Liu X, et al
    Letter to "Body Mass Index and Breast Cancer-Related Lymphedema: A Retrospective Cohort Study".
    J Surg Oncol. 2024 Dec 19. doi: 10.1002/jso.28055.
    >> Share

  49. LI F, Wei Y, Li L, Chen F, et al
    Collagen Density Is Associated With Pathological Complete Response to Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer Patients.
    J Surg Oncol. 2024 Dec 19. doi: 10.1002/jso.28046.
    >> Share

  50. NAJAFALI D, Siotos C, Kokosis G
    Taxanes and Breast Cancer-Related Lymphedema.
    J Surg Oncol. 2024 Dec 15. doi: 10.1002/jso.28017.
    >> Share

    November 2024
  51. NGUYEN A, Duckworth E, Pascua D, Coles B, et al
    Disparities in Breast Cancer Treatment and Reconstruction Among Native Hawaiian and Pacific Islander Women: Systematic Review and Meta-Analysis.
    J Surg Oncol. 2024 Nov 25. doi: 10.1002/jso.27994.
    >> Share

  52. HANNOUN-LEVI JM, Polgar C, Strnad V, Gutierrez C, et al
    With Regard to Schwieger L. et al. Intraoperative Radiation Therapy for Early-Stage Breast Cancer. DOI: 101002/jso27814.
    J Surg Oncol. 2024 Nov 11. doi: 10.1002/jso.27971.
    >> Share

    October 2024
  53. MCSHANE N, Zaborowski A, O'Reilly M, McCartan D, et al
    Hormone Receptor Positive Breast Cancer in Young Women: A Review.
    J Surg Oncol. 2024 Oct 29. doi: 10.1002/jso.27963.
    >> Share

  54. JIANG Q, Hu H, Liao J, Duan P, et al
    Body Mass Index and Breast Cancer-Related Lymphedema: A Retrospective Cohort Study.
    J Surg Oncol. 2024 Oct 28. doi: 10.1002/jso.27969.
    >> Share

  55. HANSSEN D, Champion N, Ngo J, Palfi S, et al
    Frailty and Malnutrition in Surgical Outcomes of Elderly Breast Cancer Patients.
    J Surg Oncol. 2024 Oct 10. doi: 10.1002/jso.27940.
    >> Share

  56. LIU C, Zhao H, Zhou Y
    Comment On: "Factors Influencing Prophylactic Surgical Intervention in Women With Genetic Predisposition for Breast Cancer".
    J Surg Oncol. 2024 Oct 8. doi: 10.1002/jso.27930.
    >> Share

    September 2024
  57. ALTUNDAG K
    The Association of Taxanes With Breast Cancer-Related Lymphedema.
    J Surg Oncol. 2024 Sep 19. doi: 10.1002/jso.27906.
    >> Share

  58. KU GC, Wareham C, King C, Koul A, et al
    Is Oncoplastic Surgery Safe in High-Risk Breast Cancer Phenotypes?
    J Surg Oncol. 2024 Sep 16. doi: 10.1002/jso.27899.
    >> Share

  59. ZHAO H, Xu J, Zhou Y
    Comment On: "Assessing Breast Cancer-Related Lymphedema Screening and Treatment Gaps in a Safety-Net Hospital".
    J Surg Oncol. 2024 Sep 9. doi: 10.1002/jso.27894.
    >> Share

  60. HUMAR P, Balogun Z, Douglas N, Glenney A, et al
    Factors influencing prophylactic surgical intervention in women with genetic predisposition for breast cancer.
    J Surg Oncol. 2024 Sep 1. doi: 10.1002/jso.27817.
    >> Share

  61. SELBY LV, Clark E, Chen JL, Tinoco G, et al
    Use of neoadjuvant paclitaxel in breast angiosarcoma-Impact on surgical resection and response rates.
    J Surg Oncol. 2024;130:579-585.
    >> Share

    August 2024
  62. SCHWIEGER L, Switchenko JM, Cao Y, Amaniera I, et al
    Intraoperative radiation therapy for early-stage breast cancer.
    J Surg Oncol. 2024 Aug 29. doi: 10.1002/jso.27814.
    >> Share

  63. SIOTOS C, Arnold SH, Seu M, Lunt L, et al
    Breast cancer-related lymphedema: A comprehensive analysis of risk factors.
    J Surg Oncol. 2024 Aug 27. doi: 10.1002/jso.27841.
    >> Share

  64. ALTUNDAG K
    Women with breast cancer who have second primary malignancies: Further information is still needed.
    J Surg Oncol. 2024 Aug 9. doi: 10.1002/jso.27809.
    >> Share

  65. STEADMAN JA, Hieken TJ
    Advances from targeted therapy for non-metastatic HER2-positive inflammatory breast cancer.
    J Surg Oncol. 2024 Aug 5. doi: 10.1002/jso.27797.
    >> Share

  66. LOU Y, Qu M
    Letter to the Editor: Comment on: "Reliability of artificial intelligence chatbot responses to frequently asked questions in breast surgical oncology".
    J Surg Oncol. 2024;130:347-348.
    >> Share

  67. YANG AZ, Hyland CJ, Miller AS, Killelea BK, et al
    Local practice variations and payer differences underlie state-wide disparities in oncoplastic breast surgery.
    J Surg Oncol. 2024;130:210-221.
    >> Share

  68. DAUNGSUPAWONGM H, Wiwanitkit V
    Reliability of artificial intelligence chatbot responses to frequently asked questions in breast surgical oncology: Correspondence.
    J Surg Oncol. 2024;130:338.
    >> Share

  69. ROLDAN-VASQUEZ E, Mitri S, Bhasin S, Bharani T, et al
    Reliability of artificial intelligence chatbot responses to frequently asked questions in breast surgical oncology.
    J Surg Oncol. 2024;130:188-203.
    >> Share

    July 2024
  70. CHEN C, Tseng J, Amersi F, Silberman AW, et al
    Second primary malignancies in women with breast cancer.
    J Surg Oncol. 2024 Jul 19. doi: 10.1002/jso.27785.
    >> Share

  71. GARAYUA-CRUZ L, Broida SE, Okuno SH, Robinson SI, et al
    Outcomes of non-angiosarcoma radiation-associated soft tissue sarcomas of the chest.
    J Surg Oncol. 2024;130:56-63.
    >> Share

  72. UPADHYAY N, Wolska J
    Imaging the dense breast.
    J Surg Oncol. 2024;130:29-35.
    >> Share

  73. BOLAND MR
    Modern management of the axilla.
    J Surg Oncol. 2024;130:23-28.
    >> Share

    June 2024
  74. HYAMS DM, Bareket-Samish A, Rocha JEB, Diaz-Botero S, et al
    Selecting postoperative adjuvant systemic therapy for early-stage breast cancer: An updated assessment and systematic review of leading commercially available gene expression assays.
    J Surg Oncol. 2024 Jun 24. doi: 10.1002/jso.27692.
    >> Share

  75. KELLEY K, Sener SF
    Who still needs surgical staging of the axilla for invasive breast cancer?
    J Surg Oncol. 2024 Jun 21. doi: 10.1002/jso.27753.
    >> Share

  76. YOUNG S, Geary A, Zhao X, Kenzik K, et al
    Assessing breast cancer-related lymphedema screening and treatment gaps in a safety-net hospital.
    J Surg Oncol. 2024 Jun 14. doi: 10.1002/jso.27735.
    >> Share

  77. SALGADO MRT, Sobral DV, Martins MR, Salgado EFMT, et al
    Expression of CD28, FAS, PD1, and CTLA4 molecules in the blood of women with triple-negative breast cancer.
    J Surg Oncol. 2024 Jun 6. doi: 10.1002/jso.27725.
    >> Share

  78. SOBRAL DV, Salgado MRT, Martins MR, Vasconcelos CS, et al
    Prognostic role of SOX2 and STAT3 expression on circulating T lymphocytes and CD44+/CD24(neg) cells in the locally advanced and metastatic breast cancer.
    J Surg Oncol. 2024 Jun 2. doi: 10.1002/jso.27716.
    >> Share

  79. CHEN JC, Handley D, Elsaid MI, Fisher JL, et al
    Racial disparities in disease-specific mortality and surgical management of patients with ductal carcinoma in situ with microinvasion.
    J Surg Oncol. 2024;129:1179-1186.
    >> Share

  80. AMBIKA M, Lara S, Faulkner HR, Toncred S, et al
    Oncoplastic reconstruction with breast-conserving treatment versus breast-conserving treatment alone in the elderly.
    J Surg Oncol. 2024;129:1187-1191.
    >> Share

  81. KIM M, Vingan P, Boe LA, Tadros AB, et al
    Nonresponse data in sexual well-being among breast reconstruction patients-who are we overlooking?
    J Surg Oncol. 2024;129:1192-1201.
    >> Share

  82. REYES-MONASTERIO A, Moller MG, Lozada-Martinez ID, Narvaez-Rojas AR, et al
    Bridging frontiers: The role of a Global Breast Research Working Group.
    J Surg Oncol. 2024;129:1507-1514.
    >> Share

  83. KIM M, Ali B, Graziano FD, Colvin K, et al
    Analyzing mastectomy and reconstruction weight in immediate autologous breast reconstruction: A preliminary study.
    J Surg Oncol. 2024;129:1466-1474.
    >> Share

    May 2024
  84. DI PACE B, Padley RH
    Enhancing treatment compliance in breast cancer patients: A multi-faceted approach.
    J Surg Oncol. 2024 May 27. doi: 10.1002/jso.27679.
    >> Share

  85. DI PACE B, Padley RH
    Breast cancer survivorship: A viewpoint.
    J Surg Oncol. 2024 May 19. doi: 10.1002/jso.27680.
    >> Share

  86. KEATING N, Cevik J, Hopkins D, Lippey J, et al
    Malignant upgrade rate and associated clinicopathologic predictors for concordant intraductal papilloma without atypia: A systematic review and meta-analysis.
    J Surg Oncol. 2024;129:1025-1033.
    >> Share

  87. SPIEKERMAN VAN WEEZELENBURG MA, Daemen JHT, van Kuijk SMJ, van Haaren ERM, et al
    Seroma formation after mastectomy: A systematic review and network meta-analysis of different flap fixation techniques.
    J Surg Oncol. 2024;129:1015-1024.
    >> Share

  88. DI PACE B, Padley RH
    Survivorship and breast cancer: Navigating the continuum of care.
    J Surg Oncol. 2024 May 1. doi: 10.1002/jso.27671.
    >> Share

    April 2024
  89. ABAHSSAIN H, Souadka A
    Navigating the complexity of post-NAT therapy in breast cancer: The role of ctDNA testing.
    J Surg Oncol. 2024 Apr 23. doi: 10.1002/jso.27658.
    >> Share

  90. NTOWE KW, Lee MS, Plichta JK
    Clinical genetics in breast cancer.
    J Surg Oncol. 2024 Apr 1. doi: 10.1002/jso.27630.
    >> Share

  91. SPIEKERMAN VAN WEEZELENBURG MA, de Rooij L, Aldenhoven L, van Kuijk SMJ, et al
    Drain-free mastectomy and flap fixation: The interim analysis of a randomized controlled noninferiority trial.
    J Surg Oncol. 2024;129:975-980.
    >> Share

    March 2024
  92. VALENTE S, Roesch E
    Breast cancer survivorship.
    J Surg Oncol. 2024 Mar 27. doi: 10.1002/jso.27627.
    >> Share

    December 2023
  93. ROCHLIN DH, Matros E, Shamsunder MG, Rubenstein R, et al
    Plastic surgery market share of breast reconstructive procedures: An analysis of two nationwide databases.
    J Surg Oncol. 2023;128:1064-1071.
    >> Share

  94. DE LA CRUZ KU G, Camarlinghi M, Mallouh MP, Torres-Roman JS, et al
    The impact of body mass index on oncoplastic breast surgery: A multicenter analysis.
    J Surg Oncol. 2023;128:1052-1063.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016